Page last updated: 2024-08-24

ibutilide and vernakalant

ibutilide has been researched along with vernakalant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domanovits, H; Herkner, H; Laggner, AN; Niederdoeckl, J; Schuetz, N; Simon, A; Skyllouriotis, E; Spiel, AO; Weiser, C	1

Trials

1 trial(s) available for ibutilide and vernakalant

Article	Year
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2017, 02-01, Volume: 19, Issue:2 Topics: Adult; Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Pyrrolidines; Sulfonamides; Time Factors; Treatment Outcome	2017

Article

Year

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2017, 02-01, Volume: 19, Issue:2

Topics: Adult; Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Pyrrolidines; Sulfonamides; Time Factors; Treatment Outcome

2017